Dapagliflozin Evaluation on Atrial Fibrillation Patients Followed Cox Maze IV Procedure

Conditions:   Atrial Fibrillation Recurrence;   Cox Maze IV;   Atrial Fibrillation;   Patients With or Without Heart Failure and Diabetes Interventions:   Drug: Dapagliflozin;   Drug: Placebo Sponsor:   Kun Hua Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials